Dulaglutide in Youth with Type 2 Diabetes (T2D) -Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial

被引：1
|
作者：
Arslanian, Silva A.
Cho, Jang Ik
Hannon, Tamara S.
Zeitler, Philip
Chao, Lily
Barrientos, Margarita
Boucher-Berry, Claudia C.
Bismuth, Elise
Dib, Sergio A.
Cox, David
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-5-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Dulaglutide versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1)
    Wysham, Carol
    Blevins, Thomas
    Arakaki, Richard
    Colon, Gildred
    Garcia, Pedro
    Atisso, Charles
    Kuhstoss, Debra
    Scism-Bacon, Jamie
    Lakshmanan, Mark
    DIABETES, 2013, 62 : A16 - A16
  • [42] Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
    Ludvik, Bernhard
    Frias, Juan P.
    Tinahones, Francisco J.
    Wainstein, Julio
    Jiang, Honghua
    Robertson, Kenneth E.
    Garcia-Perez, Luis-Emilio
    Woodward, D. Bradley
    Milicevic, Zvonko
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 370 - 381
  • [43] Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Singh, Pawan Kumar
    Hota, Debasish
    Dutta, Pinaki
    Sachdeva, Naresh
    Chakrabarti, Amitava
    Srinivasan, Anand
    Singh, Inderjeet
    Bhansali, Anil
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11): : E2105 - E2108
  • [44] Youth with Type 2 Diabetes (T2D) Have More Vitamin D Deficiency than Youth with Type 1 Diabetes (T1D): The Pediatric Diabetes Consortium (PDC)
    Wood, Jamie
    Bacha, Fida
    Willi, Steven M.
    Cengiz, Eda
    Tamborlane, William V.
    Gregg, Brigid
    Klingensmith, Georgeanna J.
    Schatz, Desmond A.
    Ruedy, Katrina
    Beck, Roy W.
    Kollman, Craig
    Connor, Crystal
    Haro, Heidi
    DIABETES, 2014, 63 : A389 - A390
  • [45] Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
    Maurice B. Bizino
    Ingrid M. Jazet
    Jos J. M. Westenberg
    Huub J. van Eyk
    Elisabeth H. M. Paiman
    Jan W. A. Smit
    Hildebrandus J. Lamb
    Cardiovascular Diabetology, 18
  • [46] Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial
    Beyza Eliuz Tipici
    Ender Coskunpinar
    Derya Altunkanat
    Penbe Cagatay
    Beyhan Omer
    Sukru Palanduz
    Ilhan Satman
    Ferihan Aral
    European Journal of Nutrition, 2023, 62 : 2155 - 2164
  • [47] Efficacy and safety of dulaglutide versus placebo and exenatide in type 2 diabetes (AWARD-1)
    Wysham, C.
    Blevins, T.
    Arakaki, R.
    Colon, G.
    Garcia, P.
    Atisso, C.
    Kuhstoss, D.
    Scism-Bacon, J.
    Lakshmanan, M.
    DIABETOLOGIA, 2013, 56 : S367 - S367
  • [48] Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
    Wysham, Carol
    Blevins, Thomas
    Arakaki, Richard
    Colon, Gildred
    Garcia, Pedro
    Atisso, Charles
    Kuhstoss, Debra
    Lakshmanan, Mark
    DIABETES CARE, 2014, 37 (08) : 2159 - 2167
  • [49] Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial
    Tipici, Beyza Eliuz
    Coskunpinar, Ender
    Altunkanat, Derya
    Cagatay, Penbe
    Omer, Beyhan
    Palanduz, Sukru
    Satman, Ilhan
    Aral, Ferihan
    EUROPEAN JOURNAL OF NUTRITION, 2023, 62 (05) : 2155 - 2164
  • [50] Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: A randomized, placebo-controlled trial
    Sohrab, Golbon
    Nasrollahzadeh, Javad
    Zand, Hamid
    Amiri, Zohreh
    Tohidi, Maryam
    Kimiagar, Masoud
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (03): : 215 - 220
12345